DAFNA Capital Management’s Clovis Oncology, Inc. CLVS Stock Holding History

DAFNA Capital Management’s Portfolio CLVS Stock Details CLVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-23,090	Closed	-$2.03M	–	93
2015 Q2	$2.03M	Sell	23,090 -310	-1%	-$26.5K	1.72%	21
2015 Q1	$1.74M	Sell	23,400 -500	-2%	-$35.3K	1.33%	20
2014 Q4	$1.34M	Sell	23,900 -13,000	-35%	-$683K	1.06%	26
2014 Q3	$1.67M	Buy	+36,900	New	+$1.54M	1.69%	16
2014 Q2	–	Sell	-12,600	Closed	-$873K	–	51
2014 Q1	$873K	Hold	12,600	–	–	0.75%	28
2013 Q4	$759K	Buy	+12,600	New	+$685K	0.78%	30

Other funds holding CLVS

Fidelity Investments

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

PFM Health Sciences San Francisco, California $950M AUM 57.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return

Antipodean Advisors New York $19.5M AUM 6.21% 1-Year Est. Return

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

OrbiMed New York $4.59B AUM 125.28% 1-Year Est. Return